Erin Goode

Erin Goode

Auto-generated profile, based on publicly available information

Erin Goode

Central Michigan University College of Medicine, Children’s Hospital of Michigan, Detroit, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
EGErin Do Goode
Erin Do Goode
DSDevangi Bs Shah
Devangi Bs Shah
EHElizabeth S. Ma Ver Hoeve
Elizabeth S. Ma Ver Hoeve
LALindsay M. Anderson
Lindsay M. Anderson
AWAlexandra Walsh
Alexandra Walsh
Purpose: Adolescent and young adult (AYA) cancer survivors experience treatment-related late effects so guidelines recommend providing a treatment summary, yearly follow-up, and risk-adapted testing. AYA survivors’ knowledge of surveillance follow-up was studied. Results: Survey responses for 73 AYAs were stratified: low (0 to 1 correct; n=18; 24.7%) versus high knowledge (2 to 4 correct; n=55; 75.3%) of their required testing. Patient-reported Outcomes Measurement Information System (PROMIS) scores fell within average ranges for participant age (T-scores: 52.4 for physical function, 49.3 for anxiety, 46.3 for depression, and 44.7 for fatigue). Younger age at survivorship visit was a significant predictors of improved knowledge scores. Conclusion: Despite attendance at a survivorship clinic, minority of participants (9.5%) demonstrated complete knowledge of surveillance testing needs. Most survivors are aware of some of their surveillance needs. PROMIS scores were not associated with surveillance knowledge.

1 May 2022 in JCO Precision Oncology
Verified
Journal Article
Open access
EGErin Goode
Erin Goode
LMLiliana Montoya
Liliana Montoya
EGEric Graham
Eric Graham
BPBrianna Pruniski
Brianna Pruniski
CSCurtis Simmons
Curtis Simmons
RMRoss Mangum
Ross Mangum
SHH medulloblastoma from GNAS mutation (molecular profiling confirmation) with osteoma cutis & syndromic features.

16 August 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
EGErin Goode
Erin Goode
JSJaron A. Smith
Jaron A. Smith
MGMaryam Gilpatrick
Maryam Gilpatrick
CMChelsea Matney
Chelsea Matney
BBBo Borch‐Christensen
Bo Borch‐Christensen
MHMichael M. Henry
Michael M. Henry

31 January 2024
Verified
Preprint
Open access
EGErin Goode
Erin Goode
JSJaron Smith
Jaron Smith
MGMaryam Gilpatrick
Maryam Gilpatrick
CMChelsea Matney
Chelsea Matney
BBBo Borch-Christensen
Bo Borch-Christensen
MHMichael Henry
Michael Henry
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of lymphocyte apoptosis characterized by nonmalignant lymphadenopathy, splenomegaly, immune dysregulation, and autoimmune cytopenias. Langerhans cell histiocytosis (LCH) is a neoplasm of myeloid precursor cells, primarily presenting as bone, soft tissue, lung, skin, and pituitary lesions. The association between the two diagnoses is uncharacterized. Here we describe a patient presenting with fever of unknown origin, cytopenias, and failure to thrive. She was diagnosed with ALPS, then subsequently LCH, within three months. This case highlights the diagnostic and management challenges associated with these two rare diagnoses.

15 August 2022
Verified
Preprint
Open access
PDF file
EGErin Goode
Erin Goode
PPPaulo Pena
Paulo Pena
ARAshnaa Rao
Ashnaa Rao
SSSanjay Shah
Sanjay Shah
Diamond-Blackfan Anemia (DBA) is a rare congenital bone marrow failure syndrome typically diagnosed during infancy and is characterized by macrocytic anemia, congenital malformations, and predisposition to cancer. There were 32 patients treated for DBA at a single tertiary care referral center from 2000-2022. A retrospective chart review characterized patient presentation at diagnosis, the clinical course of each patient, and the various treatment strategies with correlation to patient outcome. Our study emphasizes the importance of screening for DBA in patients who present with macrocytic anemia regardless of age at presentation as a substantial proportion of patients presented after infancy.

19 July 2026 in Clinical Pediatrics
Verified
Journal Article
Closed access
LLLeighann Leslie
Leighann Leslie
EGErin Goode
Erin Goode
MEMuna Elsiddig
Muna Elsiddig
KGKate Gowans
Kate Gowans
BBBrian Berman
Brian Berman